Article
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
17 Apr 2018
Abstract excerpt
Neurodegenerative diseases represent a class of fatal brain disorders for which the number of effective therapeutic options remains limited with only symptomatic treatment accessible. Multiple studies show that defects in sphingolipid pathways are shared among different brain disorders including neurodegenerative diseases and may contribute to their complex pathogenesis. In this mini review, we discuss the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
